| LINE ITEM (USD / %) | FY 2025
FILED 2025-12-31 | FY 2024
FILED 2024-12-31 | FY 2023
FILED 2023-12-31 |
|---|---|---|---|
| Revenue (Total Sales) | $28.44B | $33.66B | $35.13B |
| YoY Revenue Growth % | -15.5% | -4.2% | — |
| Gross Profit | $5.71B | $7.59B | — |
| Gross Margin % | 20.1% | 22.6% | — |
| Research & Development (R&D) | — | — | — |
| Operating Income (EBIT) | $2.80B | $4.91B | $5.43B |
| Operating Margin % | 9.9% | 14.6% | 15.5% |
| Net Income (GAAP) | $2.38B | $4.16B | $4.60B |
| EBITDA (Normalized) | $3.40B | $5.58B | $6.69B |
| Diluted EPS ($/sh) | — | — | — |
| Operating Cash Flow (OCF) | $4.42B | $4.64B | $4.19B |
| Capital Expenditures (CapEx) | $743.0M | $838.7M | $1.58B |
| Free Cash Flow (FCF) | $3.67B | $3.80B | $2.61B |
| FCF Margin % | 12.9% | 11.3% | 7.4% |
| Return on Invested Capital (ROIC %) | 8.9% | 16.9% | 16.8% |
| Cash & Short-Term Equivalents | — | — | — |
| Total Debt (Short + Long Term) | $10.37B | $10.16B | $9.86B |
| Total Stockholders' Equity | $19.26B | $17.51B | $20.23B |